Skip to main content

Onglyza (Saxagliptin) and Januvia (Sitagliptin) & Hospitalized Heart Failure and Acute Myocardial Infarction (AMI)

Basic Details
Status
Complete
Last Updated
Friday, February 2, 2018
Health Outcome(s)
Hospitalized heart failure
acute myocardial infarction (AMI)
Purpose
Mini-Sentinel
Regulatory Determination / Use

Advisory Committee Presentation 

Result(s) (1)
Anti-Diabetes Drugs and Acute Myocardial Infarction, Hospitalized Heart Failure
Regulatory Link(s) (1)
Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Materials
Related Publication(s) and/or Presentation(s) (2)
Publication: Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study Publication: Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based Study